Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melissa D Johnson

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Infectious Disease Clinics of North America|May 21, 2021
Antifungals in Clinical Use and the PipelineMelissa D Johnson
Current Infectious Disease Reports|September 18, 2001
Fungal Infections of the Bones and JointsMelissa D. Johnson, John R. Perfect
Expert Opinion on Pharmacotherapy|May 13, 2003
Caspofungin: first approved agent in a new class of antifungalsMelissa D Johnson, John R Perfect
Drugs in Context|February 27, 2023
Leveraging diagnostic stewardship within antimicrobial stewardship programmesKimberly C Claeys, Melissa D Johnson
Infectious Disease Clinics of North America|March 20, 2025
Current Antifungals and the Developing PipelineMelissa D Johnson, W Justin Moore
Current Fungal Infection Reports|June 25, 2010
Use of Antifungal Combination Therapy: Agents, Order, and TimingMelissa D Johnson, John R Perfect
Current Clinical Microbiology Reports|August 23, 2016
Genetic Susceptibility to Fungal Infections: What is in the Genes?Stacey A Maskarinec, Melissa D Johnson, John R Perfect
BMC Research Notes|November 4, 2011
Ertapenem for treatment of osteomyelitis: a case seriesNeela D Goswami, Melissa D Johnson, Vivian H Chu
Pharmacotherapy|November 25, 2005
Pharmacotherapy for human immunodeficiency virus-associated nephropathyScott D Pope, Melissa D Johnson, D Byron May
Memory (Hove, England)|April 26, 2005
The wane of childhood amnesia for autobiographical and public event memoriesKristi S Multhaup, Melissa D Johnson, Jonathan C Tetirick
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Infectious Disease Clinics of North America|May 21, 2021
Antifungals in Clinical Use and the PipelineMelissa D Johnson
Current Infectious Disease Reports|September 18, 2001
Fungal Infections of the Bones and JointsMelissa D. Johnson, John R. Perfect
Expert Opinion on Pharmacotherapy|May 13, 2003
Caspofungin: first approved agent in a new class of antifungalsMelissa D Johnson, John R Perfect
Drugs in Context|February 27, 2023
Leveraging diagnostic stewardship within antimicrobial stewardship programmesKimberly C Claeys, Melissa D Johnson
Infectious Disease Clinics of North America|March 20, 2025
Current Antifungals and the Developing PipelineMelissa D Johnson, W Justin Moore
Current Fungal Infection Reports|June 25, 2010
Use of Antifungal Combination Therapy: Agents, Order, and TimingMelissa D Johnson, John R Perfect
Current Clinical Microbiology Reports|August 23, 2016
Genetic Susceptibility to Fungal Infections: What is in the Genes?Stacey A Maskarinec, Melissa D Johnson, John R Perfect
BMC Research Notes|November 4, 2011
Ertapenem for treatment of osteomyelitis: a case seriesNeela D Goswami, Melissa D Johnson, Vivian H Chu
Pharmacotherapy|November 25, 2005
Pharmacotherapy for human immunodeficiency virus-associated nephropathyScott D Pope, Melissa D Johnson, D Byron May
Memory (Hove, England)|April 26, 2005
The wane of childhood amnesia for autobiographical and public event memoriesKristi S Multhaup, Melissa D Johnson, Jonathan C Tetirick
Pageof 8